Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Application window for the creation of procedures and IVD tests now open in France

On June 01, 2023, the French National Authority for Health (HAS) announced the start of the application period for the evaluation of procedures and IVD tests to be included in the 2024 HAS working program.

Applications should concern registration, removal, or modification of registration conditions for services in the various nomenclatures (Common classification of medical acts (CCAM), General nomenclature of professional acts (NGAP), and Nomenclature of medical biology acts (NABM)). The requests must be made by the relevant National Professional Council (CNP).

The application dossiers can be submitted by 23:59:59 on October 03, 2023. The new platform for dossier submission, EVActe, should be used from the HAS webpage.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.